You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: August 10, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Tazarotene patents expire, and when can generic versions of Tazarotene launch?

Tazarotene is a drug marketed by Cosette, Fougera Pharms Inc, and Taro Pharms. and is included in three NDAs.

The generic ingredient in TAZAROTENE is tazarotene. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the tazarotene profile page.

US ANDA Litigation and Generic Entry Outlook for Tazarotene

A generic version of TAZAROTENE was approved as tazarotene by TARO PHARMS on April 3rd, 2017.

  Start Trial

Drug patent expirations by year for TAZAROTENE
Drug Prices for TAZAROTENE

See drug prices for TAZAROTENE

Recent Clinical Trials for TAZAROTENE

Identify potential brand extensions & 505(b)(2) entrants

Dana-Farber Cancer InstitutePhase 2
Assiut UniversityPhase 4
Dr. Reddy's Laboratories LimitedPhase 2

See all TAZAROTENE clinical trials

Pharmacology for TAZAROTENE
Drug ClassRetinoid

US Patents and Regulatory Information for TAZAROTENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette TAZAROTENE tazarotene CREAM;TOPICAL 208662-001 Dec 22, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Fougera Pharms Inc TAZAROTENE tazarotene CREAM;TOPICAL 211175-001 Jan 28, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Taro Pharms TAZAROTENE tazarotene CREAM;TOPICAL 208258-001 Apr 3, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.